Pharmacokinetics of Repeat Oral Doses of Dabrafenib and the Combination of Dabrafenib and Trametinib in Chinese Subjects With Melanoma
Clinical trial NCT02447939 · WITHDRAWN
Trial details
- NCT number
- NCT02447939
- Sponsor
- GlaxoSmithKline
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2018-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.